1. Home
  2. SONO vs ZLAB Comparison

SONO vs ZLAB Comparison

Compare SONO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

HOLD

Current Price

$17.84

Market Cap

2.2B

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$17.53

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONO
ZLAB
Founded
2002
2013
Country
United States
China
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2018
2017

Fundamental Metrics

Financial Performance
Metric
SONO
ZLAB
Price
$17.84
$17.53
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$17.00
$57.22
AVG Volume (30 Days)
1.6M
1.0M
Earning Date
02-05-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,443,276,000.00
$441,629,000.00
Revenue This Year
$4.35
$30.20
Revenue Next Year
$7.90
$34.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.14
52 Week Low
$7.63
$16.82
52 Week High
$19.82
$44.34

Technical Indicators

Market Signals
Indicator
SONO
ZLAB
Relative Strength Index (RSI) 47.23 28.42
Support Level $17.54 $16.82
Resistance Level $18.40 $18.29
Average True Range (ATR) 0.55 0.63
MACD -0.16 0.19
Stochastic Oscillator 14.47 20.59

Price Performance

Historical Comparison
SONO
ZLAB

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: